Risk factors of docetaxel-induced peripheral edema in non-small cell lung cancer treatment: a multi-institutional cohort study

Japanese Journal of Clinical Oncology · Published 2026-05-22 · DOI 10.1093/jjco/hyag091

Authors (17)

Shinsuke Yamashita, Yoshitaka Saito, Shinya Tamaki, Daisuke Hirate, Karin Wakai, Itsuki Yonezawa, Honoka Hirasawa, Hitoshi Kashiwagi, Yuki Sato, Shungo Imai, Shunsuke Nashimoto, Jun Sakakibara-Konishi, Yasushi Shimizu, Ichiro Kinoshita, Ryo Takagi, Mitsuru Sugawara, Yoh Takekuma

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Yamashita, S., Saito, Y., Tamaki, S., et al. (2026). Risk factors of docetaxel-induced peripheral edema in non-small cell lung cancer treatment: a multi-institutional cohort study. Japanese Journal of Clinical Oncology. https://doi.org/10.1093/jjco/hyag091

Related articles

• End-of-life cancer care quality in rural areas of Japan: an exploratory bereaved family survey · Japanese Journal of Clinical Oncology · 2026 · Same journal
• Developing quality indicators for supportive care in cancer treatment: a modified Delphi method · Japanese Journal of Clinical Oncology · 2026 · Same journal
• Hereditary cancer multigene panel testing in the United States and Europe: real-world constraints and implications for responsible integration in Japan · Japanese Journal of Clinical Oncology · 2026 · Same journal
• A multicenter randomized phase II/III trial of salvage treatment for refractory primary central nervous system lymphoma using tirabrutinib: JCOG2314 (ReSTART) · Japanese Journal of Clinical Oncology · 2026 · Same journal
• Resolution of peritoneal metastases in CLDN18.2-positive gastric cancer treated with CAPOX plus zolbetuximab · Japanese Journal of Clinical Oncology · 2026 · Same journal
• Reconsidering prostate cancer screening: limitations of net survival and the primacy of overall survival as an endpoint · Japanese Journal of Clinical Oncology · 2026 · Same journal
• A multicenter randomized phase III trial of weekly cisplatin chemoradiotherapy versus radiotherapy in elderly patients with head and neck squamous cell carcinoma unfit for high-dose cisplatin: JCOG2405 (ELDER-WEEKLY) · Japanese Journal of Clinical Oncology · 2026 · Same journal
• Age-standardized mortality-to-incidence ratio for lymphoma in the world · Japanese Journal of Clinical Oncology · 2026 · Same journal
• Clinical utility of tumour markers in skeletal metastasis of unknown primary at the initial visit · Japanese Journal of Clinical Oncology · 2026 · Same journal
• Influence of pathologic fractures on oncologic outcomes in extremity Ewing sarcoma: a single-institution retrospective study · Japanese Journal of Clinical Oncology · 2026 · Same journal